Cidara Therapeutics, Inc. Purchase Agreements
5 Contracts & Agreements
- Securities Purchase Agreement, dated November 20, 2024, by and among Cidara Therapeutics, Inc. and the persons party thereto (Filed With SEC on November 26, 2024)
- Asset Purchase Agreement, dated April 24, 2024, by and between Cidara Therapeutics, Inc. and NAPP Pharmaceutical Group Limited (Filed With SEC on April 29, 2024)
- Securities Purchase Agreement, dated April 23, 2024, by and among Cidara Therapeutics, Inc. and the purchasers named therein (Filed With SEC on April 24, 2024)
- Securities Purchase Agreement, dated October 19, 2017, between the Company and the purchasers listed therein (Filed With SEC on October 20, 2017)
- ASSET PURCHASE AGREEMENT ACQUISITION OF CERTAIN ASSETS OF SEACHAID PHARMACEUTICALS, INC. BY K2 THERAPEUTICS,INC. DATED AS OF MAY 30, 2014 TABLE OF CONTENTS (Filed With SEC on March 13, 2015)
